Naeem Patil, MD, PhD

Dr. Patil completed his Ph.D. in Pharmacology and Toxicology from the University of Arkansas for Medical Sciences and his clinical training from B.J. Medical College, Pune, India. His doctoral research involved studying sepsis-induced renal mitochondrial dysfunction and acute kidney injury. He completed his postdoctoral fellowship under the mentorship of Dr. Edward Sherwood and and continued as an Early Stage Investigator in the Department of Anesthesiology until 2022. Dr. Patil's Ph.D. and postdoctoral studies were supported by American Heart Association fellowship grants. His research program focused on deciphering the molecular mechanisms involved in diverse TLR ligand-induced train immunity-mediated protection against sepsis, with a focus on immunoresponsive gene 1 and mitochondrial reprogramming-induced generation of the antimicrobial metabolite, itaconate. As a Principal Investigator, his work was funded by the Shock Society Faculty Research Award and Vanderbilt Faculty Research Scholars Award. In 2022, Dr. Patil left VUMC to enter the industry sector as a medical writing manager for Vir Biotechnology.